For providers

Four Pillars in the First Hour — and Four Orders to Skip

October 29, 2026

Editorial illustration for the article "Four Pillars in the First Hour — and Four Orders to Skip"

A clinical brief for referring providers — week 2 of a 4-part series on asthma exacerbations.

A question before the clinical note: For a severe exacerbation in a patient who can swallow — oral or intravenous corticosteroids?

a) Oral b) Intravenous c) Either, no meaningful difference in onset

Dr. {{first_name}},

The four pillars of emergency management are well established. The more useful half is what turns out not to help.

The first hour decides most of it

1 · Controlled oxygen: Titrate to SpO2 93–95%; avoid routine high-flow. Pulse oximetry may overestimate saturation in hypoxemic patients with dark skin color (GINA 2026).

2 · Bronchodilators: SABA promptly and repeatedly. MDI-plus-spacer is as effective as a nebulizer for hospitalization outcomes in most patients. Add ipratropium for severe exacerbations — the combination lowers hospitalization rates versus SABA alone.

3 · Systemic corticosteroids: Within the first hour. Prednisone 40–50 mg each morning for 5–7 days. Oral preferred and equally effective. No taper needed for courses of two weeks or less.

4 · Magnesium: For non-responders — a single IV dose of 2 g over 15–30 minutes. Cochrane found reduced admissions, OR 0.75 (95% CI 0.60–0.92).

Four orders to skip

All four are advised against as routine by GINA 2026: chest X-ray, blood gases, antibiotics, sedatives. And if anaphylaxis coexists, give IM epinephrine first.

Reassess at one hour. Discharge when symptoms improve and FEV1 or PEF reaches 60–80% of predicted or personal best — both, not one.

Want this walked through with your team?

A 20-minute clinical briefing with the Chest & Sleep Team, covering the first-hour bundle, what not to order, and the one-hour reassessment. Lunch provided. No pitch — just the clinical walkthrough.

Call (847) 860-7250.

Sources: Reddel et al., GINA 2026; Zaidan et al., JAMA, 2020.

The answer

Oral — preferred and equally effective. Reserve IV or IM for patients who cannot tolerate oral intake.